ArticleLife (Basel, Switzerland)2026

Longitudinal Outcomes and Ribavirin Use in Lung Transplant Recipients with Respiratory Syncytial Virus or Human Metapneumovirus Infection: A Real-World Multicenter Cohort Study.

Miguel Jiménez-Gómez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.